These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30098214)

  • 1. YY1 binds to the E3' enhancer and inhibits the expression of the immunoglobulin κ gene via epigenetic modifications.
    Zhou X; Xian W; Zhang J; Zhu Y; Shao X; Han Y; Qi Y; Ding X; Wang X
    Immunology; 2018 Dec; 155(4):491-498. PubMed ID: 30098214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription.
    Zhou X; Xiang Y; Garrard WT
    J Immunol; 2010 Dec; 185(12):7544-52. PubMed ID: 21076060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new hypersensitive site, HS10, and the enhancers, E3' and Ed, differentially regulate Igκ gene expression.
    Zhou X; Xiang Y; Ding X; Garrard WT
    J Immunol; 2012 Mar; 188(6):2722-32. PubMed ID: 22323542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.
    Lazorchak AS; Schlissel MS; Zhuang Y
    Mol Cell Biol; 2006 Feb; 26(3):810-21. PubMed ID: 16428437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.
    Liu Z; Garrard WT
    Mol Cell Biol; 2005 Apr; 25(8):3220-31. PubMed ID: 15798207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Downstream Transcriptional Enhancer, Ed, positively regulates mouse Ig kappa gene expression and somatic hypermutation.
    Xiang Y; Garrard WT
    J Immunol; 2008 May; 180(10):6725-32. PubMed ID: 18453592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.
    Roque MC; Smith PA; Blasquez VC
    Mol Cell Biol; 1996 Jun; 16(6):3138-55. PubMed ID: 8649425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Enhancer Marks and Transcription Factor Binding Influence Vκ Gene Rearrangement in Pre-B Cells and Pro-B Cells.
    Kleiman E; Loguercio S; Feeney AJ
    Front Immunol; 2018; 9():2074. PubMed ID: 30271408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ig kappa 3'-enhancer triggers gene expression in early B lymphocytes but its activity is enhanced on B cell activation.
    Meyer KB; Teh YM; Neuberger MS
    Int Immunol; 1996 Oct; 8(10):1561-8. PubMed ID: 8921435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer.
    Pongubala JM; Atchison ML
    J Biol Chem; 1995 Apr; 270(17):10304-13. PubMed ID: 7730336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus.
    Pan X; Papasani M; Hao Y; Calamito M; Wei F; Quinn Iii WJ; Basu A; Wang J; Hodawadekar S; Zaprazna K; Liu H; Shi Y; Allman D; Cancro M; Atchison ML
    EMBO J; 2013 Apr; 32(8):1168-82. PubMed ID: 23531880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.
    Pongubala JM; Atchison ML
    Mol Cell Biol; 1991 Feb; 11(2):1040-7. PubMed ID: 1899281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 3' enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin V kappa-J kappa joining.
    Hiramatsu R; Akagi K; Matsuoka M; Sakumi K; Nakamura H; Kingsbury L; David C; Hardy RR; Yamamura K; Sakano H
    Cell; 1995 Dec; 83(7):1113-23. PubMed ID: 8548799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements.
    Satyamoorthy K; Park K; Atchison ML; Howe CC
    Mol Cell Biol; 1993 Nov; 13(11):6621-8. PubMed ID: 8413258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic Control of Long-Range Genomic Interactions at the Immunoglobulin κ Light-Chain Locus.
    Ribeiro de Almeida C; Hendriks RW; Stadhouders R
    Adv Immunol; 2015; 128():183-271. PubMed ID: 26477368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2A and CBP/p300 act in synergy to promote chromatin accessibility of the immunoglobulin κ locus.
    Sakamoto S; Wakae K; Anzai Y; Murai K; Tamaki N; Miyazaki M; Miyazaki K; Romanow WJ; Ikawa T; Kitamura D; Yanagihara I; Minato N; Murre C; Agata Y
    J Immunol; 2012 Jun; 188(11):5547-60. PubMed ID: 22544934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
    Park K; Atchison ML
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YY1-mediated enhancer-promoter communication in the immunoglobulin μ locus is regulated by MSL/MOF recruitment.
    Phongbunchoo Y; Braikia FZ; Pessoa-Rodrigues C; Ramamoorthy S; Ramachandran H; Grosschedl A; Ma F; Cauchy P; Akhtar A; Sen R; Mittler G; Grosschedl R
    Cell Rep; 2024 Jul; 43(7):114456. PubMed ID: 38990722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK/AP1 Pathway Regulates MYC Expression and BCR Signaling through Ig Enhancers in Burkitt Lymphoma Cells.
    Ding X; Wang X; Zhu X; Zhang J; Zhu Y; Shao X; Zhou X
    J Cancer; 2020; 11(3):610-618. PubMed ID: 31942184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.